Titcomb Shawn 13D/13G Filings for Gain Therapeutics, Inc. (GANX)

Titcomb Shawn 13D and 13G filings for Gain Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-03-29
11:59 am
Purchase
2021-03-2913GGain Therapeutics, Inc.
GANX
Titcomb Shawn729,737
6.100%
729,737increase
(New Position)
Filing